Total Payments
$549,330
2024 Payments
$99,262
Companies
24
Transactions
521
Medicare Patients
1,267
Medicare Billing
$126,347
Payment Breakdown by Category
Other$264,358 (48.1%)
Consulting$192,705 (35.1%)
Travel$70,535 (12.8%)
Food & Beverage$14,040 (2.6%)
Research$6,691 (1.2%)
Education$999.67 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $242,048 | 101 | 44.1% |
| Consulting Fee | $192,705 | 57 | 35.1% |
| Travel and Lodging | $70,535 | 170 | 12.8% |
| Honoraria | $16,910 | 4 | 3.1% |
| Food and Beverage | $14,040 | 164 | 2.6% |
| Unspecified | $6,691 | 7 | 1.2% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $5,400 | 2 | 1.0% |
| Education | $999.67 | 16 | 0.2% |
Payments by Type
General
$542,638
514 transactions
Research
$6,691
7 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $154,971 | 128 | $0 (2024) |
| PFIZER INC. | $95,806 | 41 | $0 (2024) |
| AMAG Pharmaceuticals, Inc. | $91,147 | 112 | $0 (2020) |
| CooperSurgical, Inc. | $65,570 | 38 | $0 (2022) |
| TherapeuticsMD, Inc. | $59,818 | 90 | $0 (2021) |
| Astellas Pharma Europe Ltd | $22,664 | 17 | $0 (2024) |
| Lupin Inc. | $12,612 | 9 | $0 (2020) |
| Radius Health, Inc. | $10,684 | 20 | $0 (2019) |
| Astellas Pharma Global Development | $8,858 | 8 | $0 (2024) |
| Amgen Inc. | $7,823 | 15 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $99,262 | 77 | Astellas Pharma US Inc ($55,442) |
| 2023 | $108,967 | 92 | Astellas Pharma US Inc ($77,668) |
| 2022 | $44,980 | 21 | PFIZER INC. ($26,620) |
| 2021 | $2,759 | 6 | SCYNEXIS, Inc. ($1,635) |
| 2020 | $32,600 | 20 | CooperSurgical, Inc. ($14,987) |
| 2019 | $97,630 | 147 | TherapeuticsMD, Inc. ($53,589) |
| 2018 | $72,063 | 78 | CooperSurgical, Inc. ($30,178) |
| 2017 | $91,069 | 80 | AMAG Pharmaceuticals, Inc. ($43,554) |
All Payment Transactions
521 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | Astellas Pharma Europe Ltd | Veozah (Drug) | Consulting Fee | Cash or cash equivalent | $1,300.00 | General |
| Category: Biological | ||||||
| 10/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,520.00 | General |
| Category: Biological | ||||||
| 10/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $371.68 | General |
| Category: Biological | ||||||
| 10/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $206.39 | General |
| Category: Biological | ||||||
| 10/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $180.92 | General |
| Category: Biological | ||||||
| 10/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Biological | ||||||
| 10/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: Biological | ||||||
| 10/04/2024 | Exeltis, USA Inc. | SLYND (Drug) | Consulting Fee | Cash or cash equivalent | $3,638.79 | General |
| Category: CONTRACEPTIVE | ||||||
| 09/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,760.00 | General |
| Category: Biological | ||||||
| 09/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Consulting Fee | Cash or cash equivalent | $975.00 | General |
| Category: Biological | ||||||
| 09/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $100.06 | General |
| 09/12/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $52.78 | General |
| 09/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $44.95 | General |
| 09/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $162.37 | General |
| 09/09/2024 | Exeltis, USA Inc. | — | Food and Beverage | In-kind items and services | $58.58 | General |
| 09/06/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $30.00 | General |
| 08/30/2024 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,850.00 | General |
| 08/29/2024 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $215.50 | General |
| 08/05/2024 | Astellas Pharma Europe Ltd | Veozah (Drug) | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| Category: Biological | ||||||
| 08/01/2024 | PFIZER INC. | DUAVEE (Drug) | Honoraria | Cash or cash equivalent | $6,660.00 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 07/26/2024 | PFIZER INC. | DUAVEE (Drug) | Travel and Lodging | In-kind items and services | $825.68 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 07/26/2024 | PFIZER INC. | DUAVEE (Drug) | Travel and Lodging | In-kind items and services | $351.92 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 07/24/2024 | Astellas Pharma Global Development | Veozah (Drug) | Consulting Fee | Cash or cash equivalent | $2,762.50 | General |
| Category: Biological | ||||||
| 06/25/2024 | PFIZER INC. | DUAVEE (Drug) | Travel and Lodging | Cash or cash equivalent | $61.45 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 05/30/2024 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,520.00 | General |
| Category: Biological | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Phase 3 Pivotal EMP (STRIVE) | Amgen Inc. | $3,340 | 1 |
| Pooled fezolinetant safety data over 52 weeks from three randomized Phase 3 studies (SKYLIGHT 1, 2 and 4) | Astellas Pharma Global Development | $2,163 | 3 |
| A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause | Astellas Pharma Global Development | $1,000 | 2 |
| Impact of Site of Care on Osteoporosis Treatment and Outcomes | Amgen Inc. | $189.07 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 8 | 700 | 814 | $230,892 | $75,511 |
| 2020 | 10 | 567 | 628 | $195,473 | $50,836 |
Total Patients
1,267
Total Services
1,442
Medicare Billing
$126,347
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 357 | 435 | $149,205 | $47,490 | 31.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 171 | 202 | $47,066 | $16,086 | 34.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 26 | 29 | $13,369 | $4,985 | 37.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 80 | 80 | $10,560 | $3,809 | 36.1% |
| 56605 | Biopsy of external female genitals, 1 lesion | Office | 2021 | 13 | 13 | $4,485 | $1,208 | 26.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 11 | 11 | $3,784 | $1,154 | 30.5% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 13 | 13 | $1,989 | $709.41 | 35.7% |
| 81003 | Automated urinalysis test | Office | 2021 | 29 | 31 | $434.00 | $69.75 | 16.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 324 | 383 | $126,390 | $32,483 | 25.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 78 | 79 | $17,854 | $5,154 | 28.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 37 | 37 | $16,317 | $3,935 | 24.1% |
| 58558 | Biopsy and/or removal of polyp of the uterus using an endoscope | Facility | 2020 | 12 | 12 | $17,796 | $2,411 | 13.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 45 | 45 | $5,940 | $2,157 | 36.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 14 | 14 | $7,014 | $1,836 | 26.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 16 | 16 | $2,080 | $1,616 | 77.7% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 15 | 15 | $951.00 | $907.62 | 95.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 15 | 15 | $975.00 | $308.44 | 31.6% |
| 81003 | Automated urinalysis test | Office | 2020 | 11 | 12 | $156.00 | $26.95 | 17.3% |
About Risa Kagan, M.D,
Risa Kagan, M.D, is a Obstetrics & Gynecology healthcare provider based in Berkeley, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336255660.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Risa Kagan, M.D, has received a total of $549,330 in payments from pharmaceutical and medical device companies, with $99,262 received in 2024. These payments were reported across 521 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($242,048).
As a Medicare-enrolled provider, Kagan has provided services to 1,267 Medicare beneficiaries, totaling 1,442 services with total Medicare billing of $126,347. Data is available for 2 years (2020–2021), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Berkeley, CA
- Active Since 08/21/2006
- Last Updated 02/25/2017
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1336255660
Products in Payments
- Veozah (Drug) $164,632
- INTRAROSA (Drug) $55,949
- Endosee (Device) $38,348
- DUAVEE (Drug) $29,965
- IMVEXXY (Drug) $24,722
- BIJUVA (Drug) $23,544
- Uterine Manipulators & Injectors (Device) $14,996
- Other Gyn Products (Device) $12,227
- MAKENA (Drug) $11,644
- Tymlos (Biological) $10,684
- MYFEMBREE (Drug) $9,810
- FERAHEME (Drug) $6,799
- ADDYI (Drug) $6,287
- BREMELANOTIDE (Drug) $4,367
- Aimovig (Biological) $3,965
- SLYND (Drug) $3,639
- ANNOVERA (Drug) $3,618
- SUNOSI (Drug) $1,604
- HTX-011 (Drug) $1,500
- ESTRACE CREAM (Drug) $1,076
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Berkeley
Dr. Cheruba Prabakar, M.d, M.D
Obstetrics & Gynecology — Payments: $7,600
Obstetrics & Gynecology $7,600
Trudi Petersen, N.p, N.P
Obstetrics & Gynecology — Payments: $1,414
Obstetrics & Gynecology $1,414
Rachel Budker, Md, MD
Obstetrics & Gynecology — Payments: $1,122
Obstetrics & Gynecology $1,122
Attia Kadri, Md, MD
Obstetrics & Gynecology — Payments: $743.56
Obstetrics & Gynecology $743.56
Dr. Pavithra Venkat, Md, MD
Obstetrics & Gynecology — Payments: $505.35
Obstetrics & Gynecology $505.35
Cindy Zhang, M.d, M.D
Obstetrics & Gynecology — Payments: $493.27
Obstetrics & Gynecology $493.27